Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 2394Neoplasms 1813Carcinoma, Non-Small-Cell Lung 1596Prostatic Neoplasms 1296Colorectal Neoplasms 1138Lung Neoplasms 981Neoplasm Metastasis 830Multiple Myeloma 791Leukemia, Myeloid, Acute 767Ovarian Neoplasms 674Pancreatic Neoplasms 661Melanoma 659Squamous Cell Carcinoma of Head and Neck 584Carcinoma, Hepatocellular 566Recurrence 562Brain Neoplasms 526Glioblastoma 512Head and Neck Neoplasms 500Stomach Neoplasms 497Triple Negative Breast Neoplasms 464Lymphoma 453Uterine Cervical Neoplasms 449Carcinoma, Renal Cell 423Precursor Cell Lymphoblastic Leukemia-Lymphoma 410Lymphoma, Non-Hodgkin 388Endometrial Neoplasms 381Sarcoma 368Lymphoma, Follicular 356Urinary Bladder Neoplasms 354Hematologic Neoplasms 351

Interventions

Surveys and Questionnaires 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Nocturia × 1 year × Clear all
NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Northwell Health

Phase NA Suspended
20 enrolled
Genitourinary

Prostatic Hyperplasia, Nocturia, Dysuria

NCT05540392 2025-10-10

An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms, Nocturia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡